Accelerating the Future of Cell & Gene Therapy

At CytoNiche, we specialize in simplifying the complex world of CGT, especially mesenchymal stem/stromal cells (MSCs) to drive the success of therapeutic commercialization. Our solutions empower you to scale up production with cost-effective, high-quality cells, so that you can focus on what you do best —— developing transformative therapeutics. By optimizing access and affordability, we accelerate the timeline for bringing groundbreaking products to market.

See What Powers Us >

Events & News

More Events&News >

Jul 02,2026

We have published our Official Statement on Product Authenticity, Intellectual Property, and Authorised Distribution for the 3D FloTrix™ miniSPIN series.

The statement outlines CytoNiche's position on product authenticity, intellectual property, and authorised distribution, and provides guidance on identifying genuine 3D FloTrix™ miniSPIN™ series products.

May 26,2026

CytoNiche Successfully Conducts High DecaGiga Cell Manufacturing Masterclass

CytoNiche successfully conducted its High DecaGiga Cell Manufacturing Masterclass, advancing scalable and automated CGT manufacturing expertise.